Customs - Tariff Book Last updated:

SA Customs Tariff (Schedule 1 Part 1) Print

Heading CD Description Unit General EU EFTA SADC
30.03 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale:
3003.10 - Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives:
3003.10.1 -- Broad spectrum penicillins:
3003.10.11 6 --- For human use kg free free free free
3003.10.12 4 --- For veterinary use, as defined in additional Note 1 kg free free free free
3003.10.2 -- Narrow spectrum penicillins:
3003.10.21 3 --- For human use kg free free free free
3003.10.22 1 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.10.30 2 -- Other kg free free free free
3003.20 - Other, containing antibiotics:
3003.20.1 -- Tetracyclines:
3003.20.11 0 --- For human use kg free free free free
3003.20.12 9 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.2 -- Chloramphenicol:
3003.20.21 8 --- For human use kg free free free free
3003.20.22 6 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.3 -- Cephalosporins:
3003.20.31 5 --- For human use kg free free free free
3003.20.32 3 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.4 -- Trimethoprim:
3003.20.41 2 --- For human use kg free free free free
3003.20.42 0 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.5 -- Macrolides:
3003.20.51 4 --- For human use kg free free free free
3003.20.52 8 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.6 -- Fluoroquinolones:
3003.20.61 7 --- For human use kg free free free free
3003.20.62 5 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.7 -- Aminoglycosides:
3003.20.71 4 --- For human use kg free free free free
3003.20.72 2 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.8 -- Other betalactams:
3003.20.81 1 --- For human use kg free free free free
3003.20.82 3 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.20.9 -- Other antibacterials:
3003.20.91 9 --- For human use kg free free free free
3003.20.92 7 --- For veterinary use, as defined in Additional Note 1 kg free free free free
3003.3 - Other, containing hormones or other products of heading 29.37:
3003.31 6 -- Containing insulin kg free free free free
3003.39 7 -- Other kg free free free free
3003.4 - Other, containing alkaloids or derivatives thereof:
3003.41 0 -- Containing ephedrine or its salts kg free free free free
3003.42 7 -- Containing pseudoephedrine (INN) or its salts kg free free free free
3003.43 3 -- Containing norephedrine or its salts kg free free free free
3003.49 -- Other:
3003.49.10 9 --- Containing codeine phosphate kg free free free free
3003.49.90 7 --- Other kg free free free free
3003.60 3 - Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter kg free free free free
3003.90 - Other:
3003.90.10 4 -- Nucleoside reverse transcriptase inhibitors (NRTIs) kg free free free free
3003.90.20 1 -- Non-nucleoside reverse transcriptase inhibitors (NNRTI's) kg free free free free
3003.90.30 9 -- Protease inhibitors (PIs) kg free free free free
3003.90.40 6 -- Entry inhibitors kg free free free free
3003.90.50 3 -- Integrase inhibitors kg free free free free
3003.90.60 0 -- Tuberculosis drugs kg free free free free
3003.90.90 2 -- Other kg free free free free

Disclaimer: Information is provided as a free service and is for reference purposes only. It does not constitute the provision of professional advice of any kind. No responsibility for any loss caused to any person acting or refraining from action as a result of any material in this publication can be accepted by the author, copyright owner or publisher. Tariff information should be confirmed with SARS.